Product Description
skin and mucosa disinfectant solution (Sourced from: https://pubmed.ncbi.nlm.nih.gov/8202868/)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Subcutaneous,Vaginal,Ophthalmic
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Algeria | Argentina | Australia | Bangladesh | Belgium | Brazil | Bulgaria | Colombia | Croatia | Egypt | France | Germany | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Italy | Malaysia | Morocco | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Russia | South Africa | Spain | Sri Lanka | Taiwan | Tunisia | United Arab Emirates | United Kingdom | United States | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|